13th Feb 2026 07:58
(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More